Santa Cruz Biotechnology delivers a wide array of TAF I p95 monoclonal antibodies for research focused on understanding this essential protein. TAF I p95 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TAF I p95, a critical component of the transcriptional machinery, plays a significant role in the regulation of gene expression and is involved in the assembly of the transcriptional pre-initiation complex. Research involving TAF I p95 has revealed its importance in cellular processes, making it a key target for studies in cancer, developmental biology, and other fields. Understanding the function and regulation of TAF I p95 can provide insights into various pathological conditions and potential therapeutic strategies. Researchers can utilize TAF I p95 monoclonal antibodies to explore protein-protein interactions and examine expression patterns in different tissue types. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of TAF I p95 in experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of transcriptional regulation and its impact on human health.